Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial)
Clinical trial NCT05735392 · COMPLETED
Trial details
- NCT number
- NCT05735392
- Sponsor
- Consorzio Oncotech
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2022-01-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.